Our Products
Our Products

Zerifax

Zerifax

Generic:

Rifaximin

 

Therapeutic Class:

Anti-Infective Antidiarrheal

 

Composition:

Each Zerifax tablet contains 200
mg or 550 mg of rifaximin

 

Description:

Zerifax tablet contain rifaximin,
a non-aminoglycoside semi-synthetic, nonsystemic antibiotic derived from
rifamycin. Rifaximin is a structural analog of rifampin

 

Indications:

 

Travelers’ Diarrhea:

ZERIFAX 200 mg is indicated for the treatment of patients (≥ 12 years of age) with travelers’ diarrhea caused by noninvasive strains of Escherichia coli.

 

Limitations of Use:
ZERIFAX should not be used in patients with diarrhea complicated by fever
or blood in the stool or diarrhea due to pathogens other than Escherichia
coli.

 

Irritable Bowel Syndrome with Diarrhea:
ZERIFAX is indicated for the treatment of irritable bowel syndrome with
diarrhea (IBS-D) in adults.

Hepatic Encephalopathy:
Zerifax 550 mg is indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients 18 years of age.

 

Dosage:

 

Dosage for Travelers’ Diarrhea:

The recommended dose of ZERIFAX is one 200 mg tablet taken orally three times a day for 3 days. ZERIFAX can be administered orally, with or without food.

Dosage for Irritable Bowel Syndrome with Diarrhea:

The recommended dose of ZERIFAX is one 550 mg tablet taken orally three
times a day for 14 days. Patients who experience a recurrence of symptoms
can be retreated up to two times with the same dosage regimen.

Dosage for Hepatic Encephalopathy:
The recommended dose of Zerifax is one 550 mg tablet taken orally two times
a day, with or without food.

 

Presentations:

  • Zerifax Tab 200 mg is available in pack of 10’s.
  • Zerifax Tab 550 mg is available in pack of 10’s.